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KNOWLEDGE SUMMARY 
 
 
 
 
 
 
Clinical Scenario  
During a routine clinical audit of cat owner compliance with annual vaccination recommendations you notice 
that many cat owners do not attend the clinic annually for their cat’s annual health check and vaccination. A 
post audit survey of non-compliant clients indicates that some owners are reluctant to bring their cat to the 
veterinarian unless the cat is unwell because their cat becomes visibly stressed and difficult to handle. You 
are keen to adopt measures that reduce stress in cats undergoing clinical examinations so that more clients 
may be compliant with your recommendations and your feline patients less stressed by the process. To this 
end you decide to review the evidence for pharmaceutical agents that may be beneficial in achieving this 
goal. One of the pharmaceutical agents that you review is gabapentin as you have anecdotally heard positive 
reports from other veterinary professionals with regards to its use for this purpose.   
 
The evidence 
Two randomised, double-blinded, placebo controlled clinical trials (van Haaften et al., 2017; Pankratz et al., 
2018) addressed the PICO. One study (van Haaften et al., 2017) investigated the use of a single dose of 
gabapentin (100 mg) in pet cats, administered prior to exposure to transport and a veterinary examination. 
The other study (Pankratz et al., 2018) examined the use of a single dose of gabapentin (50 mg or 100 mg) in 
trapped community cats presented to a veterinary clinic for neutering. Both found a significant, stress reducing 
effect of gabapentin, although the primary outcome measures in both studies were subjective, qualitative 
ordinal behaviour based stress scores. No studies were identified that looked at the use of repeated dose 
gabapentin for management of stress over a longer time frame (e.g. during hospitalisation). Thus, there is 
moderate to strong evidence that gabapentin may be useful for reducing acute stress in cats stressed by 
veterinary interventions, but studies to demonstrate its efficacy as a pharmaceutical agent for reducing 
chronic stress in cats exposed to repeated or longer-term veterinary stressors are currently lacking. 
 
 
Summary of the evidence 
 
1. van Haaften et al. (2017) 
Population: Healthy adult mixed breed pet cats that had previously shown signs 
of stress or difficult behaviour during veterinary examination or 
transportation. 
Sample size: 20 cats 
PICO question 
In cats which are stressed as a consequence of veterinary interventions does gabapentin administration, 
compared with no gabapentin, result in lower levels of stress? 
Clinical bottom line 
There is moderate to good evidence to indicate that a single dose (100 mg) of oral gabapentin administered to 
cats might reduce signs of acute stress associated with veterinary visits. Two blinded, randomised, placebo 
controlled trials were reviewed, with consistency of direction of effect for the main outcome measure (Cat 
Stress Score) assessed. 
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Intervention details: Each cat was used as its own control, in a crossover, randomised, 
double-blinded clinical trial. 
 
Each cat had two veterinary clinic visits 1 week apart with either the 
gabapentin treatment or the placebo paired with each visit. 90 
minutes prior to placing the cat into a cat carrier and departing for 
the veterinary clinic, the owner administered one of two treatments 
orally (either in a food treat or directly into the mouth): 
1. Placebo (gelatin capsule containing 100 mg lactose powder) 
2. Gabapentin (containing 100 mg gabapentin) 
 
The order in which each cat received the treatments was 
randomised, 11 cats received gabapentin on vet visit one, and nine 
cats received the placebo on visit one. 
After arrival at the veterinary clinic, each client waited 5 minutes 
before a standardised veterinary examination was performed. The 
hospital was closed to other appointments during these periods. 
 
The standardised examination was as follows: 
- The owner remained in view of the cat but did not interact 
with the cat during the examination. 
- The cat carrier was placed on the examination table for 1 
minute. The cat was then given 2 minutes to exit the carrier 
on its own. If the cat did not exit on its own, it was gently 
removed by the veterinarian. 
- The same veterinarian and assistant performed each 
examination using gentle handling. 
- Heart rate and blood pressure was recorded.  
- The examination was prematurely ended if the cat tried to 
bite or scratch, or was assessed by the veterinarian as overly 
stressed. 
 
All evaluations were recorded on video and subsequently reviewed 
by two board certified veterinary behaviourists. 
 
The owners, veterinarian, and video observers were blinded to the 
treatments being administered. 
- Owners assigned a Cat Stress Score (CSS, Kessler & Turner, 
1997) their cat’s behaviour during: 1. Transportation to the 
veterinary clinic, and 2. The examination. 
- The veterinarian and assistant assigned a compliance score 
(CS, scale devised by the authors) to the cat’s behaviour 
regarding ease of handling.  
- The video observers assigned a CSS, CS, sedation score (SS, 
Steagall et al. 2009), and aggression score (AS, scale devised 
by the authors) for each of the cats. 
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Study design: Randomised, double-blinded, crossover trial 
Outcome studied: 1. Cat Stress Score  
(Scale: 1–7, 1 = fully relaxed; 7 = terrorised) 
2. Compliance Score 
 (scale: 0–3, 0 = no resistance to handling; 3 = extreme 
resistance to handling ± elimination) 
3. Sedation Score 
(scale: 0–4, 0 = no sedation, 4 = asleep/non-responsive to 
hand clap) 
4. Aggression Score 
(scale: 0–2, 0 = no aggressive behaviours, 2 = attempt to 
bite/swat) 
5. Heart rate 
(beats per minute) 
6. Blood pressure 
- Mean arterial pressure (MAP) 
- Systolic arterial pressure (SAP) 
7. Adverse events 
8. Miscellaneous observations 
- Able to remove the cat from its carrier at the 
veterinary clinic 
- Able to complete the veterinary examination 
(including blood pressure and heart rate 
measurement) 
 
Main findings: 
(relevant to PICO question): 
 
1. Cat Stress Score  
- Owner-assessed CSS scores during transportation 
were significantly lower when cats received 
gabapentin as compared to when they received 
placebo (mean difference: -1.65, 95% confidence 
interval, Confidence interval (CI): -2.21 to -1.09, P < 
0.001) 
- Owner-assessed (P < 0.001) but not video observer-
assessed (P = 0.06) CSS scores during veterinary 
examination were significantly lower when cats 
received gabapentin as compared to when they 
received placebo. 
- The combined owner and video observer CSS during 
the veterinary examination showed a significant 
stress-reducing effect of gabapentin, after 
controlling for order effects, other fixed effects and 
individual variation (mean difference: -0.69, 95% CI: 
-0.99 to  -0.39, P < 0.001), as compared to the 
placebo. 
2. Compliance Score 
- Veterinarians and video observers reported that cats 
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were easier to handle when gabapentin was 
administered (≤ 0.02) as compared to the placebo. 
- The combined veterinarian and video observer 
examination CS showed a significant stress reducing 
effect of gabapentin (mean difference: -0.41, 95% 
CI: -0.61 to -0.20, P < 0.001) as compared to the 
placebo. 
3. Sedation Score 
- Cats had a significantly higher SS when gabapentin 
was administered (mean difference: 0.42, 95% CI: 
0.22 to 0.62, P < 0.001) as compared to placebo.  
4. Aggression Score 
- Cats had a significantly lower AS when gabapentin 
was administered (mean difference: -0.18, 95% CI: -
0.26 to -0.09, P < 0.001) as compared to the 
placebo. 
5. Heart rate 
- Univariate analysis indicated no effect of treatment 
upon heart rate during examination. However, after 
controlling for other fixed effects, order effects and 
individual variation, the heart rate was significantly 
lower when gabapentin was administered (mean 
difference: -15.2, 95% CI: -29.5 to -0.8, P = 0.04). 
6. Blood pressure 
- MAP 
There was no significant effect of treatment on 
MAP. 
- SAP 
There was no significant effect of treatment on SAP. 
7. Adverse events 
- Adverse effects were not noted in cats administered 
the placebo. 
- Six cats administered the gabapentin exhibited 
adverse effects. Two cats vomited after 60 minutes, 
with a further one cat exhibiting signs consistent 
with nausea (hypersalivation and lip licking). A 
further three cats exhibited clinical signs during the 
examination: mild muscle twitching (n = 2) and 
unequal pupil size (n = 1). 
- Owner home reports were available for 15 of the 20 
cats. Of these 15 cats, after receiving the gabapentin 
treatment, 12 appeared sedated on arrival home 
(three markedly so), six of these also exhibited 
ataxia. Four cats were more friendly than usual, with 
one cat showing a reduction in fear to dogs. All 
clinical signs reported were temporary, and had 
disappeared within 8 hours of gabapentin 
administration.   
8. General observations relevant to the information below 
and the PICO. 
- The examination was able to be completed in 19 
cats after receiving gabapentin. 
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- The examination was not able to be completed in 
four cats after receiving the placebo. 
- The examination was not able to be completed in 
one cat after receiving gabapentin or the placebo. 
Limitations: - Small sample size 
- Inter-observer agreement between video observers 
(veterinary behaviour experts) was poor for CSS, CS, 
and SS. 
- Inter-observer agreement was only fair (Cohen k: 
0.40–0.59) between the observers who assessed CSS 
via video and the owners who assessed CSS during 
the examination (score 0.46), and poor (Cohen 
k:<0.40) between the observers who scored CS via 
video and the veterinarian who assessed CS during 
the examination (score 0.36).  Nb. The Cohen’s kappa 
statistic is a commonly used statistical test designed to assess inter-rater 
reliability and is important in that in assesses the extent to which the 
data collected represents the variable being measured (McHugh, 2012 ). 
- The methods report that an assistant (as well as the 
veterinarian) assigned a CS to each cat but this data 
does not appear in the results section. 
2. Pankratz et al. (2018) 
Population: Unowned community cats estimated to be 4 months or older, 
healthy or with mild injuries or mild systemic disease (ASA* grade I / 
II), and presented to the neutering facility in a humane cat trap. 
 
*American Society of Anesthesiologists 
Sample size: 53 cats (56 were enrolled, but 3 had an ASA score of III+ when 
examined under anaesthesia so were excluded at that point) 
Intervention details:  This was a randomised block, placebo controlled, double-blinded 
trial. There were three treatment groups: 
1. Placebo (n = 19) 
2. Low dose gabapentin (50 mg) (n = 17) 
3. High dose gabapentin (100 mg) (n = 17) 
 
Gabapentin was administered in a standardised suspension product, 
with the formulation adjusted to standardise the oral dose to 1 ml 
for each cat. Placebo cats were given the suspension only. All doses 
were supplied orally via a syringe/catheter, with the cat trapped into 
one of end of the cat trap/cage. 
 
The timeline was as follows: 
- Cats were brought to the neuter facility in traps by 
local trap-neuter-return volunteers. They were kept 
in these single cat traps and covered with a cloth 
except when it was necessary to observe the cat for 
the purpose of the study. 
- Cats were screened between 5–6pm. The time 
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between admit and screening was not defined. 
-  30 minutes after screening a baseline measurement 
was taken, followed by the treatment (placebo or 
high/low dose gabapentin). 
- Cats were then observed for the next 12 hours. They 
were fasted during this period. Study measurements 
were taken during this period. 
- At the end of the study observation period they 
were anaesthetised, clinically examined and 
neutered if entire. 
 
The relevant data time points are: 
- Screening 
- 30 minutes after screening: baseline assessment 
(pretreatment)  
- 0h (cats treated according to treatment group) 
- 1h post treatment 
- 2h post treatment 
- 3h post treatment  
- 12h post treatment 
- Post 12h (variable time point) whilst under 
anaesthesia 
 
A veterinarian blind to treatment and not involved in study data 
collection allocated cats to treatment groups (1, 2, 3) and 
administered the respective treatment. The veterinarian screening 
the cats was also blinded. It is not reported who analysed the data 
and if this was done with the analyst blinded. 
Study design: Randomised block, placebo controlled, double-blinded trial 
Outcome studied: The outcome variables were: 
1. Cat Stress Score (CSS, Kessler and Turner, 1997) 
- (Scale: 1–7, 1 = fully relaxed, 7 = terrorised) 
2. Global Sedation Score (GSS, adapted from Hopfensperger et 
al. 2013) 
- (Scale: +3 to -3, +3 = very sedated, 0 = normal, -3 = 
very excitable)   
3. Respiratory rate 
4. Facial Injury Score (FIS, scale devised by the authors) 
- (Scale: 0–4 , 0 = no injuries, 4 = severe injuries) 
5. Adverse events 
 
Outcome measures 1, 2 and 3 were measured at baseline, 1h, 2h, 3h 
and 12h post treatment. 
Outcome measure 4 was measured at baseline, 12h and while under 
anaesthetic. 
Outcome measure 5 timing was not formally reported but presumed 
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to be continuous due to the nature of the outcome. 
Main findings: 
(relevant to PICO question): 
Only the findings directly relevant to the PICO are reported here. 
 
1. Cat Stress Score  
- Compared to the placebo group, cats in the low 
dose gabapentin group had a significantly lower CSS 
at 2h (P = 0.035) and 3h (P = 0.029). 
- Compared to the placebo group, cats in the high 
dose gabapentin group had a significantly lower CSS 
at 2h (P = 0.029) and 3h (P = 0.020). 
- There was no significant difference in CSS between 
the high and low dose gabapentin groups (P = 0.79). 
- Treatment means (± standard error of the mean, 
S.E.M.) are reported as figures, so exact figures 
cannot be reported here so the reader is urged to 
obtain the paper to visualise effect size.  
2. Global Sedation Score 
- There was no treatment effect or treatment by time 
effect on GSS. 
3. Respiratory rate 
- Compared to the placebo group, cats in the high 
dose gabapentin group had a significantly lower 
respiratory rate at 1h (P = 0.03) but not at 2h (P = 
0.07) or 3h (P = 0.80). 
- There were no significant differences at any time 
point between cats in the placebo and low dose 
gabapentin groups.  
4. Facial Injury Score 
- The authors state that FIS were not sensitive to 
detection over time; therefore, the injury scores 
were not used in statistical analyses. 
5. Adverse events 
- No adverse effects that were unique to cats 
administered gabapentin were identified. 
- Four cats hypersalivated 1h post-administration of 
treatment (placebo: n =2; low dose gabapentin: n = 
1; high dose gabapentin: n = 1), with resolution of 
clinical signs by 2h post-administration.  
- No other adverse effects were noted.  
Limitations: - Small sample size 
- No description of how the CSS scores of “terrorised, 
very fearful, etc.” were assessed. Only one person 
was used to assess/score the cats and they were 
trying to assess this by looking into a cat trap. 
- The GSS used was designed for use with dogs.  
- Length of time between entry into the facility and 
screening time is unclear. 
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Appraisal, application and reflection 
 
There is moderate to good quality evidence from two randomised, controlled, double-blinded studies (van 
Haaften et al., 2017; Pankratz et al., 2018) to indicate that the use of oral gabapentin can be beneficial in the 
short-term reduction of stress in cats exposed to acute stressors associated with the veterinary clinic. One 
potential weakness relevant to both studies was that Cat Stress Score (CSS), as the main stress assessment 
tool used, showed poor or fair inter-observer reliability (only assessed by van Haaften et al., 2017). However, 
blinded observers scored the cats and the direction of any effect was similar, suggesting that this was not a 
serious issue when determining whether gabapentin had an effect (just the magnitude of the effect). 
Additional objective physiological measures to support the behavioural observations would have further 
strengthened confidence in the findings reported by each of the studies. However, the behavioural findings 
are supported by a reduction in heart rate (van Haaften et al., 2017) or respiratory rate (high dose only, 
preceded behavioural reduction, Pankratz et al., 2018).  
Both studies found that a single dose size of 100 mg/cat was associated with a reduction in the levels of 
behavioural parameters associated directly or indirectly with feline stress, and this effect was observed 90–
180 minutes post administration of the gabapentin. A similar effect was observed both in pet cats given 
gabapentin prophylactically (pre-stressor) and in unowned community (not pet) cats given gabapentin once 
already showing a behavioural stress response. However, there is some evidence (Pankratz et al., 2018) to 
suggest that a lower dose of gabapentin may be sufficient, with 50 mg/cat also being associated with a 
significantly lower CSS (but not respiratory rate) than control cats, but not significantly different from the 
high dose 100 mg/cat group. 
Whilst the Pankratz et al. (2018) study population was unowned community cats, the reported CSS of both 
control and experimental group cats was similar in both studies, which might suggest that a similar 
behavioural state and effect was observed. This may be relevant to the veterinary professional seeking to 
minimise any unwanted side effects of the medication (none in Pankratz et al., 2018; ataxia, sedation, and 
vomiting/hypersalivation in van Haaften et al., 2017) or considering repeated doses. No studies were found 
that examined the use of repeated dosing of gabapentin on feline stress levels within the clinic, but the dose 
(high, low, control) plotted against time (1h, 2h, 3h) graph in Pankratz et al. (2018) suggests a relatively short-
lived effect. This may limit clinical application for longer duration stressors (e.g. during hospitalisation 
periods), and further research to determine multiple dose efficacy or safety over longer-term stressor 
exposure would be useful. In the interim, the usefulness of single dose gabapentin to hospitalised cats could 
be improved by judicious use of procedure planning to allow potentially stressful clinical procedures to be 
performed, where possible, within the 90–180 minute period post dosing. 
 
Methodology Section 
 
Search  
Databases searched and dates 
covered: 
Pubmed (1970 – 14/04/2019); Web of Science (1970 – 14/04/2019); 
CAB Abstracts on OVID Platform (1973 – Week 14 2019) 
Search strategy: PubMed: 
(cat or cats or feline or felis or felid) and (gabapentin) and (scared or 
reactive or reactivity or emotion or emotional or fear or fearful or 
stress or stressed or anxious or anxiety or behaviour) 
 
Web of Science: 
(cat or cats or feline or felis or felid) and (gabapentin) and (scared or 
reactive or reactivity or emotion or emotional or fear or fearful or 
stress or stressed or anxious or anxiety or behaviour) 
 
CAB Abstracts: 
 (cat or cats or feline or felis or felid) and (gabapentin) and (scared or 
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reactive or reactivity or emotion or emotional or fear or fearful or 
stress or stressed or anxious or anxiety or behaviour) 
Dates searches performed: Date search performed  14/04/2019 (all databases)  
 
 
Exclusion / Inclusion Criteria 
Exclusion: Pre-defined exclusion criteria: non-English language, popular press 
articles, narrative reviews, conference abstracts 
Inclusion: Systematic reviews; any comparative (control group utilised) study 
in which the effect of prophylactic oral gabapentin on preventing or 
reducing stress, fear and anxiety in cats was studied. 
 
 
Search Outcome 
Database 
Number 
of 
results 
Excluded – 
did not 
address 
the PICO 
Excluded – not 
English 
language 
Excluded – 
conference 
abstract only 
Excluded – 
duplicate 
Total 
relevant 
papers 
Pubmed 5 3 0 0 0 2 
Web of 
Science 
12 10 0 0 2 0 
CAB 
Abstracts 
9 6 0 1 2 0 
Total relevant papers when duplicates removed 2 
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